These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 38868069)
21. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer. Zhao X; Lin J Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313 [TBL] [Abstract][Full Text] [Related]
22. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
23. Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer. Mao D; Zhou Z; Song S; Li D; He Y; Wei Z; Zhang C Front Oncol; 2021; 11():626961. PubMed ID: 33747944 [TBL] [Abstract][Full Text] [Related]
24. scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma. Lin G; Gao Z; Wu S; Zheng J; Guo X; Zheng X; Chen R Sci Rep; 2024 Feb; 14(1):3709. PubMed ID: 38355636 [TBL] [Abstract][Full Text] [Related]
25. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma. Yang C; Zhang J; Xie J; Li L; Zhao X; Liu J; Wang X Curr Stem Cell Res Ther; 2024; 19(5):767-780. PubMed ID: 37455453 [TBL] [Abstract][Full Text] [Related]
26. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma. Zhang G Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420 [TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a prognostic model for stemness-related genes in lung adenocarcinoma. Zhang H; Cao C; Xiong H Transl Cancer Res; 2024 Mar; 13(3):1351-1366. PubMed ID: 38617509 [TBL] [Abstract][Full Text] [Related]
28. A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma. Huang XY; Qin WT; Su QS; Qiu CC; Liu RC; Xie SS; Hu Y; Zhu SY Biomed Res Int; 2021; 2021():6669570. PubMed ID: 34671679 [TBL] [Abstract][Full Text] [Related]
29. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction. Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859 [TBL] [Abstract][Full Text] [Related]
30. Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma. Shi X; Liu Y; Cheng S; Hu H; Zhang J; Wei M; Zhao L; Xin S Front Oncol; 2021; 11():651622. PubMed ID: 34367952 [TBL] [Abstract][Full Text] [Related]
31. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Wang Y; Wan X; Du S Front Immunol; 2023; 14():1100100. PubMed ID: 37622118 [TBL] [Abstract][Full Text] [Related]
32. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment. Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528 [TBL] [Abstract][Full Text] [Related]
33. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients. Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338 [TBL] [Abstract][Full Text] [Related]
34. Analyzing mRNAsi-Related Genes Identifies Novel Prognostic Markers and Potential Drug Combination for Patients with Basal Breast Cancer. Huang K; Wu Y; Xie Y; Huang L; Liu H Dis Markers; 2021; 2021():4731349. PubMed ID: 34646403 [TBL] [Abstract][Full Text] [Related]
35. mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers. Zhang Y; Tseng JT; Lien IC; Li F; Wu W; Li H Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121037 [TBL] [Abstract][Full Text] [Related]
36. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer. Wang XC; Liu Y; Long FW; Liu LR; Fan CW Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362 [TBL] [Abstract][Full Text] [Related]
37. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices. Pan S; Zhan Y; Chen X; Wu B; Liu B Front Oncol; 2019; 9():613. PubMed ID: 31334127 [No Abstract] [Full Text] [Related]
38. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model. Fei H; Han X; Wang Y; Li S Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551 [TBL] [Abstract][Full Text] [Related]
39. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
40. Identification of biomarkers for acute leukemia via machine learning-based stemness index. Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H Gene; 2021 Dec; 804():145903. PubMed ID: 34411647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]